期刊文献+

原发性肝细胞癌超声造影峰值时间与肿瘤动脉密度相关性研究 被引量:4

Correlation of primary hepatocellular carcinoma between peak time of contrast enhanced ultrasound and artery density
在线阅读 下载PDF
导出
摘要 目的探讨原发性肝细胞癌超声造影峰值时间与肝癌动脉密度之间的相关性及临床意义。方法分析18例应用SonoVue进行超声造影的原发性肝细胞癌患者的声像图,确定肝癌结节的造影增强峰值时间,然后对该肿瘤结节术后病理切片在光学显微镜下进行观察,计算肿瘤内动脉血管密度(根/高倍视野),对两项观察结果进行统计学分析。结果18例患者共观察18个肿瘤结节,造影剂平均峰值时间为(18.9±2.8)s,肿瘤血管密度平均为(0.17±0.06)根/高倍视野,本组资料显示原发性肝癌造影峰值时间与肝癌瘤内动脉血管密度之间存在负相关关系,其相关系数r=-0.72,且有统计学意义(P<0.05)。结论本组资料显示原发性肝细胞癌超声造影的峰值时间与瘤内动脉密度呈明显的负相关关系,这提示通过造影峰值时间可估计肿瘤结节内的血供状况,由此可了解原发性肝细胞癌的某些生物学特性,有一定的临床意义。 Objective To approach the relation of primary hepatocellular carcinoma (PHCC) between peak time of contrast enhanced ultrasound (CEUS) and artery density and its clinical value. Methods Eighteen cases with PHCC were examined by CEUS and the peak time was recorded. After operation, the pathological sections of all cases were observed with light microscope and the artery density was calculated. Then the correlation between the peak time and the artery density was analyzed. Results In all nodules, the average peak time of CEUS was (24.60±4.33) s and the average artery density of PHCC was 0.17±0.06/HP. The correlation coefficient between them was -0.72 and it was statistically significant (P〈0.05). This indicates the peak time of CEUS become shorter as the artery density become higher. Conclusion The peak time of CEUS is inversely correlated with artery density of PHCC. This indicates we can estimate the blood supply by peak time of CEUS and the biological character for clinical therapy.
出处 《中国医学影像技术》 CSCD 北大核心 2007年第6期881-883,共3页 Chinese Journal of Medical Imaging Technology
关键词 肝细胞癌 超声造影 峰值时间 动脉密度 Hepatocellular carcinoma Contrast enhanced ultrasound Peak time Artery density
  • 相关文献

参考文献7

二级参考文献30

  • 1彭黎明.细胞凋亡检测的研究进展[J].中华医学检验杂志,1996,19(6):336-338. 被引量:23
  • 2周康荣.腹部CT[M].上海:上海医科大学出版社,1996.173-175.
  • 3[3]Lee HM, Lu DK, Krasny RM, et al. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT[J].AJR, 1997,169(1):125-130.
  • 4[4]Baron RL, Oliver JH, Dodd GD, et al. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT[J].Radiology, 1996,199(2):505-511.
  • 5[5]Ueda K, Terada T, Nakanuma Y, et al. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study[J]. Hum Pathol,1992,23(6):619-626.
  • 6[6]Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology,1991, 178(2):493-497.
  • 7Bokor D, Chambers JB, Rees PJ, et al. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol, 2001, 36:104-109.
  • 8Leen E, Angerson WJ, Yarmenitis S, et al. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur Radiol, 2002, 41: 200-206.
  • 9Strobel D, Krodel U, Martus P, et al. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound, 2000, 28:1-13.
  • 10Hosten N, Puls R, Lemke AJ, et al. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions. J Clin Ultrasound, 1999, 27: 107-115.

共引文献49

同被引文献78

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部